A Victory for IDSA’s Workforce Advocacy: NIAID Announces Significant Payline Increases
The National Institute of Allergy and Infectious Diseases has taken a major step to support the infectious diseases workforce by increasing interim paylines, or funding cutoff points, for research grants for fiscal year 2025.
Eight Institutions Receive the IDSA Antimicrobial Stewardship Center of Excellence Designation
The eight awarded institutions have created stewardship programs led by infectious diseases-trained physicians and pharmacists that advance science in antimicrobial resistance.
ASM and IDSA to Launch New Conference on Antimicrobial Resistance
The American Society for Microbiology and IDSA are excited to announce a partnership to develop an annual conference on antimicrobial resistance.
IDSA and PIDS Statement on 2024 ID Fellowship Match
IDSA and PIDS congratulate the 316 adult physicians and 43 pediatric physicians who matched today in infectious diseases. They are joining a vital and meaningful specialty that offers many pathways and opportunities throughout their careers.
IDSA Advocacy Results in Big Win for ID in 2025 Final Medicare Rule
The Centers for Medicare and Medicaid Services released its calendar year 2025 Medicare Physician Fee Schedule Final Rule on November 1, including a new add-on code for infectious diseases developed and advocated for by IDSA.
HIVMA Honors Outstanding Achievements in HIV Clinical Education and Research With 2024 Awards
The HIV Medicine Association is pleased to recognize three members during IDWeek 2024 for their contributions to advancing the field of HIV medicine.
HIVMA Names Colleen Kelley, MD, MPH, FIDSA, Chair of the Board
The HIV Medicine Association is pleased to announce the election of Colleen Kelley, MD, MPH, FIDSA, as the new chair of its Board of Directors. HIVMA is dedicated to addressing health disparities and health inequities in its mission to end the HIV epidemic.
Tina Tan, MD, FIDSA, FPIDS, FAAP, Named IDSA President
The Infectious Diseases Society of America is pleased to announce Tina Tan, MD, FIDSA, FPIDS, FAAP, as the Society’s new president beginning Oct. 20.
IDSA Honors Leaders in Infectious Diseases at IDWeek 2024
The Infectious Diseases Society of America is honored to recognize 10 outstanding experts at IDWeek 2024 for their contributions to the field of infectious diseases.
Black Individuals Less Often Vaccinated Against Influenza, SARS-CoV-2, RSV Than Whites
The overall vaccination rates for influenza, SARS-CoV-2 and RSV remain below 50%, with Black individuals less likely to be vaccinated than white individuals, even when living in similarly disadvantaged neighborhoods, according to new findings presented at IDWeek 2024.
More Than Half of Medicaid-Insured Infants Born with HIV Had No Preventative Treatment
More than half of infants insured through Medicaid who were diagnosed with HIV within one year of life did not receive postnatal antiretroviral prophylaxis, according to new findings presented at IDWeek 2024.
Mpox Vaccine Provides Strong Protection in Adolescents
A vaccine to prevent mpox is well tolerated and leads to a similar antibody response in adolescents compared to adults, according to new findings presented at IDWeek 2024.